Clinical Trial Update: Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study [Phase 3]

View source ↗

Summary

Phase 3 randomized, multicenter trial in resectable stage II-III non-small cell lung cancer evaluating SBRT followed by tislelizumab plus platinum-based chemoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Yang Hong | Conditions: Lung Cancer (NSCLC) | Phase 3 | Status: RECRUITING